Johnson Free Cash Flow Yield vs Capex To Revenue Analysis

JNJ Stock

USD 155.01 0.39 0.25%

Johnson Johnson financial indicator trend analysis is infinitely more than just investigating Johnson Johnson recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Johnson Johnson is a good investment. Please check the relationship between Johnson Johnson Free Cash Flow Yield and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

Free Cash Flow Yield vs Capex To Revenue

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Johnson Johnson Free Cash Flow Yield account and Capex To Revenue. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Johnson Johnson's Free Cash Flow Yield and Capex To Revenue is -0.32. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Johnson Johnson, assuming nothing else is changed. The correlation between historical values of Johnson Johnson's Free Cash Flow Yield and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Johnson Johnson are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Free Cash Flow Yield i.e., Johnson Johnson's Free Cash Flow Yield and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Johnson Johnson's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Johnson Johnson current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.At this time, Johnson Johnson's Tax Provision is relatively stable compared to the past year. Issuance Of Capital Stock is expected to hike to about 4.5 B this year, although Enterprise Value Multiple will most likely fall to 10.10.

	2021	2022	2023	2024 (projected)
Gross Profit	55.3B	55.4B	58.4B	34.3B
Total Revenue	78.7B	80.0B	85.2B	49.3B

Gross Profit Total Revenue

Johnson Johnson fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Property Plant And Equipment Gross
Total Assets		0.93	0.8	0.92	0.73	0.85	0.66	0.92	0.58	0.96	0.49	0.38	0.85	-0.61	0.9	0.96	0.36	-0.72	0.96	0.64	0.35	0.74	0.88	0.85	0.13	0.67
Short Long Term Debt Total	0.93		0.8	0.89	0.57	0.73	0.83	0.81	0.44	0.96	0.51	0.22	0.79	-0.59	0.94	0.85	0.19	-0.68	0.97	0.49	0.35	0.79	0.83	0.69	0.02	0.63
Other Current Liab	0.8	0.8		0.93	0.29	0.52	0.7	0.8	0.29	0.88	0.69	-0.1	0.56	-0.79	0.77	0.82	0.12	-0.84	0.88	0.18	0.12	0.56	0.72	0.47	-0.21	0.84
Total Current Liabilities	0.92	0.89	0.93		0.53	0.67	0.72	0.9	0.42	0.93	0.73	0.15	0.68	-0.74	0.79	0.92	0.34	-0.83	0.93	0.42	0.4	0.58	0.81	0.66	-0.01	0.86
Total Stockholder Equity	0.73	0.57	0.29	0.53		0.92	0.33	0.58	0.48	0.57	0.24	0.78	0.85	0.03	0.51	0.65	0.63	-0.21	0.55	0.95	0.54	0.58	0.8	0.87	0.52	0.28
Property Plant And Equipment Net	0.85	0.73	0.52	0.67	0.92		0.46	0.7	0.56	0.76	0.23	0.59	0.97	-0.17	0.74	0.77	0.46	-0.43	0.75	0.85	0.34	0.79	0.91	0.92	0.26	0.36
Net Debt	0.66	0.83	0.7	0.72	0.33	0.46		0.48	-0.14	0.77	0.51	-0.02	0.55	-0.35	0.75	0.55	0.01	-0.42	0.78	0.21	0.28	0.73	0.69	0.27	0.06	0.51
Retained Earnings	0.92	0.81	0.8	0.9	0.58	0.7	0.48		0.66	0.87	0.52	0.32	0.68	-0.78	0.76	0.98	0.28	-0.89	0.87	0.53	0.26	0.49	0.73	0.81	0.07	0.77
Cash	0.58	0.44	0.29	0.42	0.48	0.56	-0.14	0.66		0.46	0.08	0.43	0.51	-0.47	0.45	0.62	0.32	-0.53	0.46	0.52	0.16	0.23	0.35	0.78	-0.06	0.3
Non Current Assets Total	0.96	0.96	0.88	0.93	0.57	0.76	0.77	0.87	0.46		0.51	0.13	0.81	-0.66	0.94	0.92	0.24	-0.75	0.99	0.44	0.25	0.8	0.84	0.73	-0.08	0.69
Non Currrent Assets Other	0.49	0.51	0.69	0.73	0.24	0.23	0.51	0.52	0.08	0.51		-0.03	0.22	-0.51	0.26	0.51	0.44	-0.54	0.48	0.15	0.62	0.07	0.42	0.23	-0.01	0.8
Cash And Short Term Investments	0.38	0.22	-0.1	0.15	0.78	0.59	-0.02	0.32	0.43	0.13	-0.03		0.48	0.2	0.16	0.32	0.36	0.05	0.16	0.92	0.41	0.17	0.46	0.63	0.85	-0.02
Net Receivables	0.85	0.79	0.56	0.68	0.85	0.97	0.55	0.68	0.51	0.81	0.22	0.48		-0.2	0.81	0.75	0.36	-0.45	0.8	0.76	0.29	0.86	0.93	0.86	0.15	0.38
Common Stock Shares Outstanding	-0.61	-0.59	-0.79	-0.74	0.03	-0.17	-0.35	-0.78	-0.47	-0.66	-0.51	0.2	-0.2		-0.56	-0.72	0.06	0.9	-0.67	0.06	0.01	-0.17	-0.3	-0.35	0.32	-0.77
Non Current Liabilities Total	0.9	0.94	0.77	0.79	0.51	0.74	0.75	0.76	0.45	0.94	0.26	0.16	0.81	-0.56		0.82	0.02	-0.65	0.96	0.42	0.06	0.89	0.81	0.68	-0.08	0.48
Inventory	0.96	0.85	0.82	0.92	0.65	0.77	0.55	0.98	0.62	0.92	0.51	0.32	0.75	-0.72	0.82		0.34	-0.83	0.91	0.57	0.27	0.6	0.8	0.84	0.08	0.76
Other Current Assets	0.36	0.19	0.12	0.34	0.63	0.46	0.01	0.28	0.32	0.24	0.44	0.36	0.36	0.06	0.02	0.34		-0.03	0.16	0.54	0.69	0.05	0.35	0.5	0.19	0.29
Other Stockholder Equity	-0.72	-0.68	-0.84	-0.83	-0.21	-0.43	-0.42	-0.89	-0.53	-0.75	-0.54	0.05	-0.45	0.9	-0.65	-0.83	-0.03		-0.76	-0.16	-0.03	-0.33	-0.53	-0.54	0.26	-0.82
Total Liab	0.96	0.97	0.88	0.93	0.55	0.75	0.78	0.87	0.46	0.99	0.48	0.16	0.8	-0.67	0.96	0.91	0.16	-0.76		0.45	0.21	0.8	0.85	0.71	-0.05	0.68
Total Current Assets	0.64	0.49	0.18	0.42	0.95	0.85	0.21	0.53	0.52	0.44	0.15	0.92	0.76	0.06	0.42	0.57	0.54	-0.16	0.45		0.5	0.45	0.73	0.83	0.67	0.2
Short Term Debt	0.35	0.35	0.12	0.4	0.54	0.34	0.28	0.26	0.16	0.25	0.62	0.41	0.29	0.01	0.06	0.27	0.69	-0.03	0.21	0.5		0.04	0.32	0.37	0.35	0.34
Intangible Assets	0.74	0.79	0.56	0.58	0.58	0.79	0.73	0.49	0.23	0.8	0.07	0.17	0.86	-0.17	0.89	0.6	0.05	-0.33	0.8	0.45	0.04		0.8	0.6	-0.03	0.21
Accounts Payable	0.88	0.83	0.72	0.81	0.8	0.91	0.69	0.73	0.35	0.84	0.42	0.46	0.93	-0.3	0.81	0.8	0.35	-0.53	0.85	0.73	0.32	0.8		0.77	0.26	0.57
Common Stock Total Equity	0.85	0.69	0.47	0.66	0.87	0.92	0.27	0.81	0.78	0.73	0.23	0.63	0.86	-0.35	0.68	0.84	0.5	-0.54	0.71	0.83	0.37	0.6	0.77		0.24	0.4
Short Term Investments	0.13	0.02	-0.21	-0.01	0.52	0.26	0.06	0.07	-0.06	-0.08	-0.01	0.85	0.15	0.32	-0.08	0.08	0.19	0.26	-0.05	0.67	0.35	-0.03	0.26	0.24		-0.09
Property Plant And Equipment Gross	0.67	0.63	0.84	0.86	0.28	0.36	0.51	0.77	0.3	0.69	0.8	-0.02	0.38	-0.77	0.48	0.76	0.29	-0.82	0.68	0.2	0.34	0.21	0.57	0.4	-0.09

Click cells to compare fundamentals

Johnson Johnson Account Relationship Matchups

Johnson Johnson fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	157.7B	174.9B	182.0B	187.4B	167.6B	175.9B
Short Long Term Debt Total	27.7B	35.3B	33.8B	39.6B	29.3B	30.8B
Other Current Liab	26.2B	29.0B	29.3B	30.9B	30.2B	31.7B
Total Current Liabilities	36.0B	42.5B	45.2B	55.8B	46.3B	48.6B
Total Stockholder Equity	59.5B	63.3B	74.0B	76.8B	68.8B	38.7B
Property Plant And Equipment Net	17.7B	18.8B	19.0B	18.0B	19.9B	11.6B
Net Debt	10.4B	21.3B	19.3B	26.8B	7.5B	7.8B
Retained Earnings	110.7B	113.9B	123.1B	128.3B	153.8B	161.5B
Cash	17.3B	14.0B	14.5B	12.9B	21.9B	23.0B
Non Current Assets Total	112.5B	123.7B	121.0B	132.1B	114.1B	119.8B
Non Currrent Assets Other	4.5B	6.6B	10.2B	30.6B	14.2B	14.9B
Cash And Short Term Investments	19.3B	25.2B	31.6B	22.3B	22.9B	14.3B
Net Receivables	14.5B	13.6B	15.3B	14.0B	14.9B	8.0B
Common Stock Shares Outstanding	2.7B	2.7B	2.7B	2.7B	2.6B	2.2B
Liabilities And Stockholders Equity	157.7B	174.9B	182.0B	187.4B	167.6B	175.9B
Non Current Liabilities Total	62.3B	69.1B	62.8B	54.8B	52.5B	55.1B
Inventory	9.0B	9.3B	10.4B	10.3B	11.2B	11.7B
Other Current Assets	2.5B	3.1B	3.7B	8.7B	4.5B	3.5B
Other Stockholder Equity	(38.4B)	(38.5B)	(39.1B)	(41.7B)	(75.7B)	(71.9B)
Total Liab	98.3B	111.6B	108.0B	110.6B	98.8B	103.7B
Total Current Assets	45.3B	51.2B	61.0B	55.3B	53.5B	31.1B
Short Term Debt	1.2B	2.6B	3.8B	12.8B	3.5B	3.0B
Intangible Assets	47.6B	53.4B	46.4B	38.5B	34.2B	18.7B
Accounts Payable	8.5B	9.5B	11.1B	9.9B	9.6B	5.4B
Short Term Investments	2.0B	11.2B	17.1B	9.4B	1.1B	1.0B
Property Plant And Equipment Gross	18.6B	18.8B	47.7B	49.3B	47.8B	50.2B
Accumulated Other Comprehensive Income	(15.9B)	(15.2B)	(13.1B)	(13.0B)	(12.5B)	(11.9B)
Other Liab	35.1B	35.4B	31.8B	26.6B	30.6B	18.8B
Other Assets	11.4B	3.9B	17.2B	17.0B	19.6B	20.6B
Long Term Debt	26.5B	32.6B	30.0B	26.9B	25.9B	15.4B
Good Will	33.6B	36.4B	35.2B	36.0B	36.6B	21.5B
Treasury Stock	(38.4B)	(38.5B)	(39.1B)	(41.7B)	(75.7B)	(71.9B)
Property Plant Equipment	17.7B	18.8B	19.0B	19.8B	22.8B	15.8B
Current Deferred Revenue	1.9B	7.6B	7.8B	3.0B	3.4B	4.5B
Net Tangible Assets	(21.8B)	(26.5B)	(13.1B)	(16.8B)	(15.1B)	(14.3B)
Retained Earnings Total Equity	110.7B	113.9B	123.1B	128.3B	147.6B	110.0B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Johnson Johnson is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Johnson Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Johnson Johnson Stock. Highlighted below are key reports to facilitate an investment decision about Johnson Johnson Stock:

How To Invest In Johnson

Details

Is Johnson Stock a good investment?

Details

What is Johnson Johnson's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.89)

Dividend Share

4.86

Earnings Share

6.05

Revenue Per Share

36.428

Quarterly Revenue Growth

0.052

The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Johnson Free Cash Flow Yield vs Capex To Revenue Analysis

Free Cash Flow Yield vs Capex To Revenue

Free Cash Flow Yield vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Capex To Revenue

Johnson Johnson fundamental ratios Correlations

Johnson Johnson Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Johnson Johnson fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.99	Non Current Assets Total
Inventory	+ 0.98	Retained Earnings
Total Liab	+ 0.97	Short Long Term Debt Total
Net Receivables	+ 0.97	Property Plant And Equipment Net
Non Current Assets Total	+ 0.96	Total Assets
Inventory	+ 0.96	Total Assets

Other Stockholder Equity	- 0.89	Retained Earnings
Other Stockholder Equity	- 0.84	Other Current Liab
Other Stockholder Equity	- 0.83	Inventory
Other Stockholder Equity	- 0.83	Total Current Liabilities
Property Plant And Equipment Gross	- 0.82	Other Stockholder Equity
Common Stock Shares Outstanding	- 0.79	Other Current Liab